Sanofi charged with Manslaughter over birth defects linked to its epilepsy drug Depakine Ruchika Sharma4 Aug 2020 1:37 PM ISTThe charges relate to the drug valproate, marketed as Depakine among other trade names, which studies say has caused disabilities in about...
Serum Institute gets DCGI nod for clinical trials of Oxford vaxine MD Bureau3 Aug 2020 10:51 AM ISTNew Delhi: The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of...
Sun Pharma factory pollutants within Vedanthangal Bird Sanctuary poses threat to humans, birds; claims study Farhat Nasim2 Aug 2020 3:00 PM ISTChennai: Drug major Sun Pharma is likely to fall in the limelight as a study conducted by the Chennai Climate Action Group and Community Environmental...
Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics Ruchika Sharma1 Aug 2020 11:42 AM ISTPost the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.
Maharashtra: Medical equipment supplier loses Rs 1.3 crore to fraudsters Farhat Nasim31 July 2020 4:23 PM ISTMumbai: In a shocking incident, a city-based surgical and medical equipment supplier has recently been duped of Rs 1.3 crore by three persons,...
Ensure equitable distribution of Remdesivir, Tocilizumab drugs: Health Ministry directs DCGI Ruchika Sharma30 July 2020 12:34 PM ISTNew Delhi: The Union health ministry has asked the Drugs Controller General of India (DCGI) to ensure equitable distribution of Remdesivir and...
Biocon to furnish more data for consideration of Itolizumab in treating COVID patients Farhat Nasim29 July 2020 4:24 PM ISTBengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration...
Alembic Pharma to raise Rs 1000 crore via QIP issue of equity shares Ruchika Sharma28 July 2020 4:52 PM ISTNew Delhi: Gujarat-based drug firm, Alembic Pharmaceuticals, on Monday said its board has shown a green signal to raise up to Rs 1,000 crore...
Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19 Ruchika Sharma27 July 2020 3:59 PM ISTNew Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical...
NPPA revises ceiling price of Budesonide upholding DOP review order; Details Farhat Nasim26 July 2020 11:15 AM ISTNew Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the National...
Landmark: Indian Pharmacopoeia Commission bans animal test for batch testing of human vaccines MD Bureau24 July 2020 8:51 PM ISTNew Delhi: The Indian Pharmacopoeia Commission has removed the 'abnormal toxicity test' from the human vaccine monographs of the Indian Pharmacopoeia...
DCGI nod to two cheaper favipiravir versions priced at Rs 59, Rs 39 per tablets Farhat Nasim24 July 2020 4:55 PM ISTBriton Pharma will be marketing Favipiravir under the brand name Faviton in India and will also export it.
